Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam in neonates with repeated electroencephalographic seizures
2015-002756-27Phase 2Terminated
- Sponsor
- UCB
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of brivaracetam in neonatal seizure, sponsored by UCB. Primary endpoint: Plasma concentration of brivaracetam following first dose on Day 1. Started Mar 2017; status: terminated.
02
Drugs
brivaracetam
03
Conditions
neonatal seizure
Beyond the preview
Go deeper on 2015-002756-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002756-27.